Neoplasms study: Anal Cytology vs CINtec®PLUS
Official title Screening Strategies Among High-risk Populations for Anal Cancer
ClinicalTrials.gov ID: NCT06628570
What this study is testing
- What it's testing
- The study will look at how well new screening tests work for detecting precancerous anal lesions and will study DNA, immune, and environmental factors linked to these lesions.
- Who it's for
- The study is looking for adults who are at high risk for anal cancer.
- What's involved
- Participants will have screening tests for anal lesions, including tests that examine DNA and immune responses, and may provide information about their environment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 80. Healthy volunteers may be eligible.
You may be able to join if
- 30-80 years of age
- Individuals with chronic impaired immune status
- History of lower genital tract neoplasia (LGTN), Zubrod Performance Status of 0-2
You likely can't join if
- Patients treated for aHSIL less than 6 months before screening
- History of anal cancer and pregnant women.
The study team makes the final eligibility decision.
Where it is enrolling
- Miami, Florida, United States
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Miami, Florida, United States; Atlanta, Georgia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.